LivaNova PLC - Ordinary Shares (LIVN)
Frequently Asked Questions About LivaNova PLC - Ordinary Shares (LIVN)
Has LivaNova made any recent acquisitions?
LivaNova has actively pursued strategic acquisitions to enhance its portfolio and capabilities. For instance, in recent years, the company acquired the neuromodulation business of ImThera Medical, which expanded its offerings in sleep apnea treatments. These acquisitions reflect LivaNova's strategy of advancing innovation and improving patient care through broader product capabilities.
How can I invest in LivaNova PLC?
To invest in LivaNova PLC, individuals can purchase shares through a brokerage firm that provides access to the Nasdaq stock exchange, where LivaNova is listed under the ticker symbol 'LIVN.' Potential investors should conduct thorough research, consider their investment strategy, and consult with a financial advisor if necessary to make informed decisions regarding investment in LivaNova.
How does LivaNova address the challenges of the global healthcare market?
LivaNova addresses challenges in the global healthcare market by focusing on patient-centric innovations and adapting its product offerings to meet diverse regional needs. The company collaborates with healthcare professionals and stakeholders worldwide to identify clinical challenges, ensuring that its solutions are relevant and effective in various healthcare settings.
How does LivaNova engage with investors?
LivaNova actively engages with its investors through transparent communication, regular financial reporting, and participation in investor conferences. The company aims to provide stakeholders with updated information on business performance, strategic initiatives, and future growth opportunities, fostering trust and encouraging constructive dialogue between management and investors.
How does LivaNova ensure product quality and safety?
LivaNova maintains stringent quality management systems and adheres to international regulatory standards to ensure the safety and effectiveness of its products. The company conducts comprehensive testing and validation processes during product development and post-market surveillance to monitor performance and address any safety concerns, ensuring that healthcare providers and patients can trust their products.
How does LivaNova support patient and physician education?
LivaNova actively supports patient and physician education through various initiatives, including training programs, online resources, and collaborative partnerships with healthcare institutions. The company aims to empower healthcare professionals with the knowledge and skills needed to effectively use its products, ultimately leading to better patient care and improved outcomes.
Is LivaNova publicly traded?
Yes, LivaNova PLC is publicly traded on the Nasdaq stock exchange under the ticker symbol 'LIVN.' As a publicly listed company, LivaNova is subject to regulatory requirements and must publicly disclose financial information, providing transparency to its investors and stakeholders.
What are some of LivaNova's notable products?
Some of LivaNova's notable products include the CardioHelp system for extracorporeal life support, the VNS Therapy system for epilepsy and depression treatment, and the DLM (Dual-Lumen) cannula for cardiac surgeries. These products exemplify LivaNova's commitment to developing innovative technologies that address pressing health challenges.
What are the key areas of focus for LivaNova?
LivaNova primarily focuses on three key areas: cardiac surgery, neuromodulation, and advanced therapies. In cardiac surgery, the company offers products such as heart-lung machines and perfusion systems. In neuromodulation, they specialize in products aimed at treating epilepsy and depression through advanced therapies. These areas reflect LivaNova's commitment to addressing critical healthcare needs.
What are the major risks facing LivaNova?
Like many companies in the medical technology sector, LivaNova faces several risks, including regulatory challenges, market competition, and potential product liability issues. Changes in healthcare regulations or reimbursement policies could impact product sales and operations. Additionally, the company must continually innovate to maintain a competitive edge in the market, which requires a sustained investment in research and development.
What awards or recognitions has LivaNova received?
LivaNova has received various awards and recognitions in the medical technology field for its innovative products and practices. The company is frequently acknowledged for its contributions to improving patient care, particularly in cardiology and neuromodulation, demonstrating its commitment to excellence and advancement in healthcare technologies.
What corporate social responsibility initiatives does LivaNova participate in?
LivaNova engages in various corporate social responsibility (CSR) initiatives aimed at enhancing community health and well-being. This includes supporting global health programs, advocating for patient access to treatments, and contributing to philanthropic efforts that improve healthcare delivery and education in underserved regions. These initiatives reflect LivaNova's commitment to making a positive impact beyond its core business operations.
What does LivaNova PLC do?
LivaNova PLC is a global medical technology company that specializes in developing and marketing products for cardiac surgery, neuromodulation, and advanced therapies. The company focuses on innovative solutions to improve patient outcomes and enhance the quality of care. LivaNova's notable product lines include heart-lung machines, neuromodulation devices for epilepsy and depression treatments, and surgical solutions for cardiac procedures.
What is LivaNova's approach to innovation?
LivaNova prioritizes innovation through robust research and development initiatives, partnering with healthcare professionals and institutions worldwide to identify unmet medical needs. By investing in new technologies and leveraging the latest scientific advancements, LivaNova aims to develop cutting-edge solutions that improve the quality of life for patients and streamline hospital operations.
What is LivaNova's commitment to sustainability?
LivaNova is committed to sustainability by integrating environmentally responsible practices into its operations and product development. The company focuses on reducing its carbon footprint, enhancing the sustainability of its supply chain, and ensuring that its products are developed with minimal environmental impact. This commitment aligns with LivaNova's broader mission to improve global health.
What is LivaNova's vision for the future?
LivaNova's vision for the future centers on transforming the landscape of global healthcare through technological innovation and collaboration. The company aims to develop groundbreaking therapies that enhance patient care, while also fostering relationships with the medical community to address emerging healthcare challenges and improve patient outcomes sustainably.
What role does research and development play at LivaNova?
Research and development (R&D) play a crucial role at LivaNova, with a significant portion of resources allocated to this area. The R&D teams work on both incremental and revolutionary advancements in product technology, ensuring that LivaNova stays at the forefront of medical innovation. This investment facilitates the development of new therapies and the enhancement of existing products to meet evolving patient needs.
When was LivaNova PLC founded?
LivaNova PLC was formed in 2015 as a result of the merger between Sorin Group, a company known for cardiovascular devices, and Cyberonics, a leader in neuromodulation therapies. This merger aimed to leverage the strengths of both organizations and create a comprehensive portfolio in the medical technology sector, particularly focusing on improving patient outcomes.
Where is LivaNova PLC headquartered?
LivaNova PLC is headquartered in London, United Kingdom. The company's central location allows it to operate efficiently across global markets, facilitating better access to healthcare systems and enhancing its ability to collaborate internationally in developing innovative medical technologies.
Who are LivaNova's main competitors?
LivaNova faces competition from various global medical device companies, particularly in the fields of cardiac surgery and neuromodulation. Key competitors include Medtronic, Boston Scientific, Abbott Laboratories, and Edwards Lifesciences, which also develop advanced technologies for cardiovascular issues and neuromodulation applications.
What is the current price of LivaNova PLC - Ordinary Shares?
The current price of LivaNova PLC - Ordinary Shares is 36.79
When was LivaNova PLC - Ordinary Shares last traded?
The last trade of LivaNova PLC - Ordinary Shares was at 4:00 pm EDT on May 1st, 2025
What is the market capitalization of LivaNova PLC - Ordinary Shares?
The market capitalization of LivaNova PLC - Ordinary Shares is 1.80B
How many shares of LivaNova PLC - Ordinary Shares are outstanding?
LivaNova PLC - Ordinary Shares has 49.02M shares outstanding.